CD86 and neoplasm: STAT3 inhibition not only promotes the maturation of tumor-infiltrating dendritic cells to express the costimulatory molecules, such as CD80 and CD86, necessary for T cell activation, but also induces a shift in tumor immune cell composition toward less MDSCs and immunosuppressive macrophages/microglia [118,119,120,121].